Xilio Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Xilio Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Xilio Therapeutics Inc
Rating: 1.20933325
Author: Trendlyne DVM scores

about

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

0.60 -0.01 (-1.64%)

64.71% Fall from 52W High

524.2K

XNAS Volume

XNAS 30 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Bearish

33.5 / 100

1Yr Price target upside is 233%

1 analysts

Xilio Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xilio Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

64.71% Fall from 52W High

SWOT Analysis

Xilio Therapeutics Inc Live Price Chart